Lixte Biotechnology Shares Down on Plans for Nomad Transportable Power Deal, Name Change

Dow Jones
06/13
 

By Josh Beckerman

 

Shares of Lixte Biotechnology Holdings declined after it announced plans to buy battery energy company Nomad Transportable Power Systems and change Lixte's name to Nomad Power Solutions.

The stock was down 12% to $6.41 in Friday afternoon trading. Shares are up 63% this year.

Cancer-drug developer Lixte said June 1 that it would transform into an AI energy infrastructure equipment and services business, and seek a strategic acquisition partner for its pharmaceutical and medical technology operations.

Lixte didn't disclose a deal price for Nomad. The company said Nomad's revenue rose about 175% in 2025. Lixte said Nomad's mobile utility-grade battery energy storage systems have a structural permitting and deployment advantage, offering an alternative to permanent BESS projects that "routinely face development timelines of two to five years or longer."

 

Write to Josh Beckerman at josh.beckerman@wsj.com

 

(END) Dow Jones Newswires

June 12, 2026 13:48 ET (17:48 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10